BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature. In addition, the company provides products for medical cooling treatments for diseases, such as stroke, cardiac arrest, migraine, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.
Frequently asked questions
What sector does BRAINCOOL AB (5YL) operate in?
BRAINCOOL AB belongs to the Healthcare sector and operates in the Medical Devices industry.
What is BRAINCOOL AB (5YL) current stock price?
As of the latest data, BRAINCOOL AB stock price is €0.06, with a previous close of €0.06. BRAINCOOL AB lost -€0.00 in the last trading session, representing a -0.93% loss.
What is BRAINCOOL AB (5YL) current market capitalization?
BRAINCOOL AB market cap is approximately 25.27 million.
What is BRAINCOOL AB (5YL) Earnings Per Share (EPS)?
The trailing EPS is -€0.01.
Does BRAINCOOL AB (5YL) pay dividends?
No. BRAINCOOL AB does not pay a dividend.
What is BRAINCOOL AB (5YL) beta (volatility) score?
BRAINCOOL AB has a beta of 1.443, suggesting it is more volatile than the market.
